DRUG.AX vs. HVST.AX
DRUG.AX (Betashares Global Healthcare Currency Hedged ETF) and HVST.AX (Betashares Australian Dividend Harvester Active ETF) are both exchange-traded funds - DRUG.AX is a Health & Biotech Equities fund tracking the Nasdaq Global ex-Australia Healthcare Hedged AUD Index, while HVST.AX is a Dividend fund actively managed by BetaShares. DRUG.AX is passively managed, while HVST.AX is actively managed. Over the past 5 years, DRUG.AX returned 4.03%/yr vs 4.38%/yr for HVST.AX. At a 0.42 correlation, their price movements are largely independent.
Performance
DRUG.AX vs. HVST.AX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DRUG.AX achieves a 1.49% return, which is significantly higher than HVST.AX's -1.27% return.
DRUG.AX
- 1D
- 1.89%
- 1M
- 5.32%
- 6M
- 0.23%
- YTD
- 1.49%
- 1Y
- 17.07%
- 3Y*
- 6.21%
- 5Y*
- 4.03%
- 10Y*
- —
HVST.AX
- 1D
- -0.53%
- 1M
- -1.34%
- 6M
- -1.92%
- YTD
- -1.27%
- 1Y
- -0.57%
- 3Y*
- 7.14%
- 5Y*
- 4.38%
- 10Y*
- 2.42%
DRUG.AX vs. HVST.AX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DRUG.AX Betashares Global Healthcare Currency Hedged ETF | 1.49% | 11.83% | 1.82% | 0.76% | -3.68% | 23.60% | 4.75% | 21.95% | 2.11% | 18.34% |
HVST.AX Betashares Australian Dividend Harvester Active ETF | -1.27% | 6.89% | 10.85% | 8.84% | -3.51% | 8.41% | -2.12% | 13.98% | -6.21% | -10.08% |
Correlation
The correlation between DRUG.AX and HVST.AX is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.43 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.43 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.44 |
Correlation (All Time) Calculated using the full available price history since Aug 4, 2016 | 0.42 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DRUG.AX vs. HVST.AX — Risk / Return Rank
DRUG.AX
HVST.AX
DRUG.AX vs. HVST.AX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Betashares Global Healthcare Currency Hedged ETF (DRUG.AX) and Betashares Australian Dividend Harvester Active ETF (HVST.AX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DRUG.AX | HVST.AX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.11 | ||
| Sortino ratioReturn per unit of downside risk | +1.68 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.00 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 1.56 | -0.06 | +1.62 |
| Martin ratioReturn relative to average drawdown | 3.72 | -0.12 | +3.85 |
Loading charts...
Drawdowns
DRUG.AX vs. HVST.AX - Drawdown Comparison
The maximum DRUG.AX drawdown since its inception was -26.79%, which is greater than HVST.AX's maximum drawdown of -23.38%. Use the drawdown chart below to compare losses from any high point for DRUG.AX and HVST.AX.
Loading charts...
Drawdown Indicators
| DRUG.AX | HVST.AX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -26.79% | -23.38% | -3.41% |
Max Drawdown (1Y)Largest decline over 1 year | -10.69% | -9.23% | -1.46% |
Max Drawdown (3Y)Largest decline over 3 years | -20.63% | -13.07% | -7.56% |
Max Drawdown (5Y)Largest decline over 5 years | -20.63% | -14.71% | -5.92% |
Max Drawdown (10Y)Largest decline over 10 years | — | -18.92% | — |
Current DrawdownCurrent decline from peak | -2.61% | -5.13% | +2.52% |
Average DrawdownAverage peak-to-trough decline | -5.17% | -9.57% | +4.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.52% | 4.53% | -0.01% |
Volatility
DRUG.AX vs. HVST.AX - Volatility Comparison
Betashares Global Healthcare Currency Hedged ETF (DRUG.AX) has a higher volatility of 6.29% compared to Betashares Australian Dividend Harvester Active ETF (HVST.AX) at 2.50%. This indicates that DRUG.AX's price experiences larger fluctuations and is considered to be riskier than HVST.AX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DRUG.AX | HVST.AX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.29% | 2.50% | +3.79% |
Volatility (6M)Calculated over the trailing 6-month period | 11.71% | 9.68% | +2.03% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.65% | 12.07% | +3.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.95% | 12.03% | +2.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.17% | 11.15% | +5.02% |
Dividends
DRUG.AX vs. HVST.AX - Dividend Comparison
DRUG.AX's dividend yield for the trailing twelve months is around 3.63%, less than HVST.AX's 4.31% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DRUG.AX Betashares Global Healthcare Currency Hedged ETF | 3.63% | 0.00% | 2.84% | 0.00% | 0.00% | 4.49% | 0.62% | 0.28% | 3.37% | 0.00% | 0.00% | 0.00% |
HVST.AX Betashares Australian Dividend Harvester Active ETF | 4.31% | 5.26% | 4.93% | 6.13% | 6.64% | 6.19% | 7.01% | 10.96% | 10.87% | 10.37% | 9.21% | 8.07% |
Frequently Asked Questions
DRUG.AX and HVST.AX have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DRUG.AX is categorized as Health & Biotech Equities, while HVST.AX is Dividend.
Find the right allocation for DRUG.AX and HVST.AX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer